Your browser doesn't support javascript.
loading
First-Line Treatment Options for PD-L1-Negative Non-Small Cell Lung Cancer: A Bayesian Network Meta-Analysis.
Peng, Ling; Liang, Wen-Hua; Mu, De-Guang; Xu, Song; Hong, Shao-Dong; Stebbing, Justin; Liang, Fei; Xia, Yang.
Afiliación
  • Peng L; Department of Respiratory Disease, Zhejiang Provincial People's Hospital, Hangzhou, China.
  • Liang WH; National Clinical Research Center for Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
  • Mu DG; Department of Respiratory Disease, Zhejiang Provincial People's Hospital, Hangzhou, China.
  • Xu S; Department of Lung Cancer Surgery, Lung Cancer Institute, Tianjin Medical University General Hospital, Tianjin, China.
  • Hong SD; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Stebbing J; Division of Cancer, Department of Surgery and Cancer, Imperial College London, London, United Kingdom.
  • Liang F; Department of Biostatistics, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Xia Y; Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Key Laboratory of Respiratory Disease of Zhejiang Province, Hangzhou, China.
Front Oncol ; 11: 657545, 2021.
Article en En | MEDLINE | ID: mdl-34249693

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies / Systematic_reviews Idioma: En Revista: Front Oncol Año: 2021 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies / Systematic_reviews Idioma: En Revista: Front Oncol Año: 2021 Tipo del documento: Article País de afiliación: China